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EPIDERMAL PROTEASE*
GEORGE C. WELLS, M.B., M.R.C.P. AND CARVELLE BABCOCK, S.B.
The object of this work was to discover something of the distribution of pro-
tease in the skin, and to work out a method for demonstrating proteolytic activ-
ity in small amounts of skin with the ideas of eventually studying some pathologic
conditions.
In 1945, Beloff and Peters (2) described in the skin of animals a proteolytic
enzyme active between pH 7.0 and 8.0. This protease could be partially extracted
from fresh skin mince or from acetone dried skin using 5% KC1 in phosphate
buffer for extractions. Fruton (5) found that saline extracts of fresh rabbit skin
yielded mostly peptidase, and a similar enzyme could be extracted from human
skin. Neville-Jones and Peters (7) confirmed that fresh extracts of skin have a
high dermopeptidase activity while extracts of acetone dried skin yielded mostly
protease. The protease was found to digest casein, serum proteins, myogen and
some proteins in the skin itself, and its pH optimum was 7.5. It was distinct from
other proteolytic enzymes active at this pH in that it did not affect the specific
substrates by which trypsin, chymotrypsin and dermopeptidase may be recog-
nized, and it is distinct from the autolytic enzymes active in a more acid pH
range. Beloff (3) found that serum albumin contained a factor which inhibited
the protease of skin. With experimental burns in animals it was noticed that the
protease would disappear from the skin (2), but that if the same amount of heat
were applied to excised skin there was no loss of protease. Beloff and Peters (2)
suggested that during burns protease was mobilized in the skin, but that it soon
reached the blood stream where it would be quickly neutralized by protease in-
hibitor (3). Cullumbine (4) showed that products of digestion of protein by skin
protease (as in vesicles from burns and vesicant gases) were active in producing
inflammation in the manner of Menkin's leukotaxin (6). It seems that peptides of
amino acid chain length between 8 and 14 would regularly produce inflammation
by causing vasodilatation and leukotaxis and Spector (9) considered that leuko-
taxin was not a specific substance but that the effect could be produced by many
polypeptides.
Thus the products of proteolysis may be of importance in burns and perhaps
in vesication, and in other conditions where the skin is damaged.
METHODS
In earlier unpublished work casein was used as a substrate and the Sorensen
formol titration as an index of proteolysis. With this method proteolytic activity
could be demonstrated in extracts of acetone dried skin from baby rats, but the
method was found to be unsuitable for small specimens of skin.
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PROTEOLYTIC ACTIVITY OF EPIDERMIS AND DERMIS.
HEMOGLOBIN SUBSTRATE.
FIG. 1
DIGESTION OF HEMOGLOBIN BY EPIDERMO-PROTEASE.
Fia. 2
The rather sharp rise in optical density in the first ten minutes of the incuba-
tion is usually seen in these experiments. Trypsin gives a similar digestion curve
by this method. Trypsin is completely inhibited by soybean trypsin inhibitor
but this same inhibitor has no effect upon the skin protease. Cysteine, heparin,
treburon and polyethanol sulfonate had no inhibiting effect on the enzyme.
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If in the process of extraction the epidermis is very finely divided sufficient pro-
tein is present in the extract to provide a substrate for the protease so that
addition of denatured hemoglobin may not always be necessary.
The work has required relatively large amounts of raw material. About 1 gm.
wet weight of epidermis would be required for initial extraction by 15 ml. of KC1
in buffer. It has been difficult to obtain such amounts of skin especially as there
is some loss of activity on prolonged storage.
Recently using microcuvettes we have been able to measure amounts of digest
sample of the order of 0.4 ml. and initial extractions can be made with 100 to 200
mg. wet weight of epidermis.
DISCUSSION
The relatively large amounts of protease which may be extracted from epider-
mis suggest that a considerable part of the dermoprotease of Beloff and Peters
may be derived from the epidermis. it is not surprising to find a proteolytic en-
zyme in the epidermis, an area that is actively proteoplastic. Living epithelial
cells exert some proteolytic action on fibrin in the course of wound healing, and
lysis of fibrin clot and digestion of egg albumen by epithelial cells in tissue culture
has been demontrated by Santesson (8). Damaged epithelial cells may release
proteolytic enzyme which in turn may produce inflammatory protein breakdown
products such as may be of importance in vesication.
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DISCUSSION
DR. ADOLPH ROSTENBERG, Chicago, Illinois: I would like to offer my congratu-
lations to Dr. Wells and his colleague for this paper. I think pure research work
such as this needs no justification but it is nice if one can make some clinical cor-
relations.
Now what I am going to say is obviously somewhat speculative. The genesis of
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many necrotic reactions of the skin is to a large degree unknown. One of the
mechanisms that may play a part in their development is the Shwartzman
phenomenon. Recently, primarily through the work of Thomas, Stetson and
Good much additional information has been gathered about the pathogenesis of
the Shwartzman reaction. It is essentially a two stage process. The first stage
is a preparatory one in which it has been shown that the bacterial ifitrates alter
the metabolism of tissue into which they are put (the skin is usually that tissue),
so that it is more vulnerable to proteolytic enzymes. Subsequently, when the
eliciting dose is given intravenously the proteolytic enzyme inhibitors are de-
pressed and consequently the tissue into which the preparatory dose was put is
no longer protected against these enzymes. One of the problems has been, where
do these enzymes come from? Dr. Wells' work offers at least a possible explana-
tion for the source of these enzymes which, when the eliciting factors are intro-
duced, cause the local necrosis. Interestingly, as he has shown you, there is a
plasma inhibitor for his enzyme and Thomas, Stetson, et al, have shown that
plasma inhibitors are markedly reduced by the secondary eliciting intravenous
injection.
DR. GEORGE C. WELLS (in closing): I appreciate Dr. Rostenberg's remarks al-
though it is a little unlikely that the enzymes, if such are released in the Shwartz-
man phenomenon, would actually be epidermal. We know little concerning the
proteolytic activity of living epithelial cells except for the fibrinolysis caused by
epidermal cells and this activity, is at the cell surface. Santesson's extensive
studies of tissue cultures of mouse mammary epithelia are of great interest. It
seems that proteolytic enzymes produced by living epithelial cells are important
in relation to the normal cell environment, and it is noticed that this enzymatic
activity is absent in most cultures of tumor cells.
